ArticleJournal of translational medicine2024

Gut metatranscriptomics based de novo assembly reveals microbial signatures predicting immunotherapy outcomes in non-small cell lung cancer.

David Dora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.